Polymorphic genetic control of tumor invasion in a mouse model of pancreatic neuroendocrine carcinogenesis

Proceedings of the National Academy of Sciences of the United States of America

Volumn 107, Issue 40, 2010, Pages 17268-17273

  Chun, Matthew G H ^a,b,c   Mao, Jian Hua ^c,d   Chiu, Christopher W ^b,c   Balmain, Allan ^c   Hanahan, Douglas ^a,b,c,e  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d LAWRENCE BERKELEY NATIONAL LABORATORY   (United States)

^e EPFL   (Switzerland)

Author keywords

Anaplastic lymphoma kinase; Cancer modifier genes; Malignant progression; Pancreas cancer; Transgenic mouse

Indexed keywords

ANAPLASTIC LYMPHOMA KINASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER INVASION; CHROMOSOME 17; CONTROLLED STUDY; GENE EXPRESSION; GENETIC LINKAGE; GENETIC REGULATION; INVASIVE CARCINOMA; MOUSE; NEUROENDOCRINE TUMOR; NONHUMAN; PANCREAS ISLET CELL CARCINOMA; POLYMORPHIC LOCUS; PRIORITY JOURNAL;

ADENOMA, ISLET CELL; ANIMALS; CELL TRANSFORMATION, NEOPLASTIC; CHROMOSOMES, MAMMALIAN; GENETIC LOCI; LINKAGE (GENETICS); MICE; MICE, INBRED C3H; MICE, INBRED C57BL; PANCREATIC NEOPLASMS; POLYMORPHISM, GENETIC; PROTEIN-TYROSINE KINASES; PYRIMIDINES;

MUS; MUS MUSCULUS;

EID: 78049256779     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1012705107     Document Type: Article

References (42)

1. Balmain A, Gray J, Ponder B (2003) The genetics and genomics of cancer. Nat Genet 33(Suppl):238-244.
2. Easton DF, et al.; SEARCH collaborators; kConFab; AOCS Management Group (2007) Genome-wide association study identifies novel breast cancer susceptibility loci. Nature 447:1087-1093. (Pubitemid 47014426)
3. Tomlinson IP, et al.; CORGI Consortium; EPICOLON Consortium (2008) A genome-wide association study identifies colorectal cancer susceptibility loci on chromosomes 10p14 and 8q23.3. Nat Genet 40:623-630. (Pubitemid 351601204)
4. Park YG, et al. (2005) Sipa1 is a candidate for underlying the metastasis efficiency modifier locus Mtes1. Nat Genet 37:1055-1062.
5. Lifsted T, et al. (1998) Identification of inbred mouse strains harboring genetic modifiers of mammary tumor age of onset and metastatic progression. Int J Cancer 77:640-644. (Pubitemid 28340915)
6. Nagase H, et al. (1995) Distinct genetic loci control development of benign and malignant skin tumours in mice. Nat Genet 10:424-429.
7. Sequist LV, Bell DW, Lynch TJ, Haber DA (2007) Molecular predictors of response to epidermal growth factor receptor antagonists in non-small-cell lung cancer. J Clin Oncol 25:587-595. (Pubitemid 350002967)
8. Hanahan D (1985) Heritable formation of pancreatic beta-cell tumours in transgenic mice expressing recombinant insulin/simian virus 40 oncogenes. Nature 315:115-122.
9. Lopez T, Hanahan D (2002) Elevated levels of IGF-1 receptor convey invasive and metastatic capability in a mouse model of pancreatic islet tumorigenesis. Cancer Cell 1:339-353.
10. Hager JH, et al. (2004) Oncogene expression and genetic background influence the frequency of DNA copy number abnormalities in mouse pancreatic islet cell carcinomas. Cancer Res 64:2406-2410.
11. Perl AK, Wilgenbus P, Dahl U, Semb H, Christofori G (1998) A causal role for Ecadherin in the transition from adenoma to carcinoma. Nature 392:190-193.
12. Gocheva V, et al. (2010) IL-4 induces cathepsin protease activity in tumor-associated macrophages to promote cancer growth and invasion. Genes Dev 24:241-255.
13. Gocheva V, et al. (2006) Distinct roles for cysteine cathepsin genes in multistage tumorigenesis. Genes Dev 20:543-556.
14. Joyce JA, Freeman C, Meyer-Morse N, Parish CR, Hanahan D (2005) A functional heparan sulfate mimetic implicates both heparanase and heparan sulfate in tumor angiogenesis and invasion in a mouse model of multistage cancer. Oncogene 24:4037-4051.
15. Lander E, Kruglyak L (1995) Genetic dissection of complex traits: Guidelines for interpreting and reporting linkage results. Nat Genet 11:241-247.
16. Quigley DA, et al. (2009) Genetic architecture of mouse skin inflammation and tumour susceptibility. Nature 458:505-508.
17. Hubner N, et al. (2005) Integrated transcriptional profiling and linkage analysis for identification of genes underlying disease. Nat Genet 37:243-253.
18. Chiarle R, Voena C, Ambrogio C, Piva R, Inghirami G (2008) The anaplastic lymphoma kinase in the pathogenesis of cancer. Nat Rev Cancer 8:11-23.
19. Ulanet DB, Ludwig DL, Kahn CR, Hanahan D (2010) Insulin receptor functionally enhances multistage tumor progression and conveys intrinsic resistance to IGF-1R targeted therapy. Proc Natl Acad Sci USA 107:10791-10798.
20. Galkin AV, et al. (2007) Identification of NVP-TAE684, a potent, selective, and efficacious inhibitor of NPM-ALK. Proc Natl Acad Sci USA 104:270-275.
21. Bergers G, Javaherian K, Lo KM, Folkman J, Hanahan D (1999) Effects of angiogenesis inhibitors on multistage carcinogenesis in mice. Science 284:808-812.
22. Demant P (2003) Cancer susceptibility in the mouse: Genetics, biology and implications for human cancer. Nat Rev Genet 4:721-734.
23. Quan L, Hutson A, Demant P (2010) A locus on chromosome 8 controlling tumor regionality - a new type of tumor diversity in the mouse lung. Int J Cancer 126:2603-2613.
24. Hodgson G, et al. (2001) Genome scanning with array CGH delineates regional alterations in mouse islet carcinomas. Nat Genet 29:459-464.
25. George RE, et al. (2008) Activating mutations in ALK provide a therapeutic target in neuroblastoma. Nature 455:975-978.
26. Mossé YP, et al. (2008) Identification of ALK as a major familial neuroblastoma predisposition gene. Nature 455:930-935.
27. Morris SW, et al. (1994) Fusion of a kinase gene, ALK, to a nucleolar protein gene, NPM, in non-Hodgkin's lymphoma. Science 263:1281-1284.
28. Li R, Morris SW (2008) Development of anaplastic lymphoma kinase (ALK) smallmolecule inhibitors for cancer therapy. Med Res Rev 28:372-412.
29. Stylianou DC, et al. (2009) Effect of single-chain antibody targeting of the ligand-binding domain in the anaplastic lymphoma kinase receptor. Oncogene 28:3296-3306.
30. Piva R, et al. (2006) Ablation of oncogenic ALK is a viable therapeutic approach for anaplastic large-cell lymphomas. Blood 107:689-697.
31. Oklü R, Hesketh R (2000) The latent transforming growth factor beta binding protein (LTBP) family. Biochem J 352:601-610.
32. Massagué J (2008) TGFbeta in Cancer. Cell 134:215-230.
33. Hill VK, et al. (2010) Identification of 5 novel genes methylated in breast and other epithelial cancers. Mol Cancer 9:51.
34. Golipour A, et al. (2008) The Spy1/RINGO family represents a novel mechanism regulating mammary growth and tumorigenesis. Cancer Res 68:3591-3600.
35. Zucchi I, et al. (2004) Gene expression profiles of epithelial cells microscopically isolated from a breast-invasive ductal carcinoma and a nodal metastasis. Proc Natl Acad Sci USA 101:18147-18152.
36. Chun MG, Hanahan D (2010) Genetic deletion of the desmosomal component desmoplakin promotes tumor microinvasion in a mouse model of pancreatic neuroendocrine carcinogenesis. PLoS Genetics, in press.
37. Wakabayashi Y, Mao JH, Brown K, Girardi M, Balmain A (2007) Promotion of Hras-induced squamous carcinomas by a polymorphic variant of the Patched gene in FVB mice. Nature 445:761-765.
38. Coussens LM, Hanahan D, Arbeit JM (1996) Genetic predisposition and parameters of malignant progression in K14-HPV16 transgenic mice. Am J Pathol 149:1899-1917.
39. Hennings H, et al. (1993) FVB/N mice: An inbred strain sensitive to the chemical induction of squamous cell carcinomas in the skin. Carcinogenesis 14:2353-2358.
40. Winter SF, Hunter KW (2008) Mouse modifier genes in mammary tumorigenesis and metastasis. J Mammary Gland Biol Neoplasia 13:337-342.
41. Hsieh SM, Look MP, Sieuwerts AM, Foekens JA, Hunter KW (2009) Distinct inherited metastasis susceptibility exists for different breast cancer subtypes: a prognosis study. Breast Cancer Res 11:R75.
42. Sambrook J, Russell DW (2001) Molecular Cloning: A Laboratory Manual (Cold Spring Harbor Lab Press, Cold Spring Harbor, NY).